BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24371234)

  • 1. Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru.
    García C; Lejon V; Horna G; Astocondor L; Vanhoof R; Bertrand S; Jacobs J
    J Clin Microbiol; 2014 Mar; 52(3):968-70. PubMed ID: 24371234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal.
    Acharya D; Trakulsomboon S; Madhup SK; Korbsrisate S
    Jpn J Infect Dis; 2012; 65(3):264-7. PubMed ID: 22627312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
    Lee CJ; Su LH; Huang YC; Chiu CH
    J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes.
    Dimitrov T; Dashti AA; Albaksami O; Udo EE; Jadaon MM; Albert MJ
    J Clin Microbiol; 2009 Jan; 47(1):208-11. PubMed ID: 18971360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
    Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.
    Al-Emran HM; Eibach D; Krumkamp R; Ali M; Baker S; Biggs HM; Bjerregaard-Andersen M; Breiman RF; Clemens JD; Crump JA; Cruz Espinoza LM; Deerin J; Dekker DM; Gassama Sow A; Hertz JT; Im J; Ibrango S; von Kalckreuth V; Kabore LP; Konings F; Løfberg SV; Meyer CG; Mintz ED; Montgomery JM; Olack B; Pak GD; Panzner U; Park SE; Razafindrabe JL; Rabezanahary H; Rakotondrainiarivelo JP; Rakotozandrindrainy R; Raminosoa TM; Schütt-Gerowitt H; Sampo E; Soura AB; Tall A; Warren M; Wierzba TF; May J; Marks F
    Clin Infect Dis; 2016 Mar; 62 Suppl 1(Suppl 1):S42-6. PubMed ID: 26933020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
    Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
    Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteraemia with pleural effusions complicating typhoid fever caused by high-level ciprofloxacin-resistant Salmonella enterica serotype Typhi.
    Mohanty S; Gaind R; Paglietti B; Paul P; Rubino S; Deb M
    Ann Trop Paediatr; 2010; 30(3):233-40. PubMed ID: 20828458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
    Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
    Mutai WC; Muigai AWT; Waiyaki P; Kariuki S
    BMC Microbiol; 2018 Nov; 18(1):187. PubMed ID: 30428828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin-resistant Salmonella enterica Serotype Typhi, United States, 1999-2008.
    Medalla F; Sjölund-Karlsson M; Shin S; Harvey E; Joyce K; Theobald L; Nygren BN; Pecic G; Gay K; Austin J; Stuart A; Blanton E; Mintz ED; Whichard JM; Barzilay EJ
    Emerg Infect Dis; 2011 Jun; 17(6):1095-8. PubMed ID: 21749779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002-2013) and molecular characterization of quinolone resistant isolates.
    Nüesch-Inderbinen M; Abgottspon H; Sägesser G; Cernela N; Stephan R
    BMC Infect Dis; 2015 May; 15():212. PubMed ID: 25963025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
    Morita M; Ito K; Hirose K; Takahashi H; Shimuta K; Terajima J; Ohnishi M; Harada M; Matsuzaki M; Watanabe H; Izumiya H
    Microbiol Immunol; 2006; 50(9):707-11. PubMed ID: 16985292
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Tanmoy AM; Westeel E; De Bruyne K; Goris J; Rajoharison A; Sajib MSI; van Belkum A; Saha SK; Komurian-Pradel F; Endtz HP
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin.
    Emary K; Moore CE; Chanpheaktra N; An KP; Chheng K; Sona S; Duy PT; Nga TV; Wuthiekanun V; Amornchai P; Kumar V; Wijedoru L; Stoesser NE; Carter MJ; Baker S; Day NP; Parry CM
    Trans R Soc Trop Med Hyg; 2012 Dec; 106(12):718-24. PubMed ID: 23122884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Detection of
    Habeeb Rasool K; Hammood Hussein N; Mahamed Taha B
    Pak J Biol Sci; 2020 Jan; 23(10):1303-1309. PubMed ID: 32981264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.